Company news

Pathkey.AI Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Opyl - Clarification Statement to Appendix 4C

May 19, 2021

Opyl - Completes successful SPP

April 21, 2021

Opyl - Clinical trial recruitment platform update

April 15, 2021

Opyl - Completes Unmarketable Share Buyback

April 8, 2021

Opyl - Capital Raising Completed & Cleansing Notice

April 6, 2021

Opyl - Completes Capital Raise and Launches SPP

March 30, 2021

Opyl - Half Year Investor Presentation

February 24, 2021

Opyl 2020 AGM Presentation

November 30, 2020

Opyl receives $249k R&D tax refund

November 26, 2020

Reinstatement to Official Quotation

September 7, 2020

Opyl achieves major milestone with AI platform

September 2, 2020

Opyl - Appendix 4E & Full Year Statutory Accounts

August 28, 2020

Opyl - Business Update and Appendix 4C

July 26, 2020

Opyl - Capital Raise Completed & Cleansing Notice

June 24, 2020

Opyl - Completes Capital Raise

June 19, 2020

Opyl - Additional Information for 20 May Announcement

May 25, 2020

Opyl - Commercial Update

May 20, 2020

Opyl - Updated March Quarter Appendix 4C

May 15, 2020

Opyl and AAMRI launch COVID-19 Social Media Guide

May 12, 2020

Opyl - Additional Commentary March Quarter 2020

May 11, 2020

Opyl receives $201K R&D incentive and tax refund

April 30, 2020

Opyl - Business Update & Half Year Report

February 28, 2020

Response to ASX Appendix 4C Query

February 27, 2020

Opyl develops clinical trial prediction software using AI

February 18, 2020

Opyl partners with hummun

February 10, 2020

Opyl - Correction to Appendix 4C

February 6, 2020

Quarterly Report - Appendix 4C

October 31, 2019

Appendix 4E and Full Year Statutory Accounts

September 1, 2019

Quarterly Report and Appendix 4C

July 31, 2019

SRO Completes Rights Issue and Placement Raises $1.2M

July 22, 2019

SRO Plan to Divest its Ludomade Business

July 5, 2019

Rights Issue Offer Booklet

July 1, 2019

Non-Renounceable Entitlement Offer and Company Update

June 24, 2019

Response to Appendix 4C Query

May 20, 2019

Michelle Gallaher appointed SRO CEO

March 14, 2019

Half Year Financial Report & Appendix 4D

February 28, 2019

Reinstatement to Trading on the ASX

February 6, 2019

Changes to Board of Directors

February 1, 2019

Pause in Trade

January 31, 2019

Appendix 4C - monthly

January 30, 2019

Cancer Trials Australia becomes MediaConsent collaborator

January 8, 2019

Capital Raise and Strategic Acquisition of Ludomade

November 15, 2018

Collaboration announced with Neuroscience Trials Australia

October 31, 2018

SRO partners with Secure One Button Login experts SAAVHA

October 25, 2018

Quarterly Report & Appendix 4C

October 23, 2018

MediaConsent collaboration with St Vincents Hospital

October 21, 2018

MediaConsent launch Pilot program with Social Media Energy

October 17, 2018

Change of Registry Address: Automic P/L - Sydney Office

September 28, 2018

Brand focused Beta launch of MediaConsent

September 26, 2018

Update on Placement of Shares and Advisory Board Appointment

July 24, 2018

← Newer news releases · Older news releases →

Decks